LONDON, UK: On 31 July 2023, the Apax XI Fund has signed a definitive agreement to acquire a co-controlling stake in Palex, the leading distributor of medical technology (MedTech) equipment and solutions in Southern Europe, alongside Fremman Capital.
The transaction is expected to close by Q4 2023, subject to customary closing conditions.
Founded in 1955 and headquartered in Barcelona, Palex is the leading independent MedTech solutions provider in Southern Europe, focused on the marketing, sales, and logistics of high value-added MedTech equipment for public and private hospitals as well as laboratories in Iberia and Italy. The Company has a strong reputation for innovation, quality, and service. It offers a wide product portfolio of over 150,000 product references from 600+ world-leading tier-1 manufacturers.
Apax’s significant global experience partnering with both MedTech and distribution-focused businesses, its digital capabilities and its operational expertise ideally positions it to partner with Palex’s management team to help fuel future growth.